106 related articles for article (PubMed ID: 10440405)
1. Tracking alloreactive cell division in vivo.
Song HK; Noorchashm H; Lieu YK; Rostami S; Greeley SA; Barker CF; Naji A
Transplantation; 1999 Jul; 68(2):297-9. PubMed ID: 10440405
[TBL] [Abstract][Full Text] [Related]
2. Quantifying the frequency of alloreactive T cells in vivo: new answers to an old question.
Suchin EJ; Langmuir PB; Palmer E; Sayegh MH; Wells AD; Turka LA
J Immunol; 2001 Jan; 166(2):973-81. PubMed ID: 11145675
[TBL] [Abstract][Full Text] [Related]
3. A direct method for the calculation of alloreactive CD4+ T cell precursor frequency.
Noorchashm H; Lieu YK; Rostami SY; Song HK; Greeley SA; Bazel S; Barker CF; Naji A
Transplantation; 1999 May; 67(9):1281-4. PubMed ID: 10342323
[TBL] [Abstract][Full Text] [Related]
4. "Pruning" of alloreactive CD4+ T cells using 5- (and 6-)carboxyfluorescein diacetate succinimidyl ester prolongs skin allograft survival.
Watson D; Zhang GY; Sartor M; Alexander SI
J Immunol; 2004 Dec; 173(11):6574-82. PubMed ID: 15557147
[TBL] [Abstract][Full Text] [Related]
5. The alloreactive and self-restricted CD4+ T cell response directed against a single MHC class II/peptide combination.
Kovalik JP; Singh N; Mendiratta SK; Martin WD; Ignatowicz L; Van Kaer L
J Immunol; 2000 Aug; 165(3):1285-93. PubMed ID: 10903728
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the alloimmune response to minor histocompatibility antigens by in vivo MLR.
Song HK; Noorchashm H; Lieu YK; Rostami S; Greeley SA; Barker CF; Naji A
Transplant Proc; 1999; 31(1-2):836-7. PubMed ID: 10083363
[No Abstract] [Full Text] [Related]
7. Effect of immunosuppressants on T-cell subsets observed in vivo using carboxy-fluorescein diacetate succinimidyl ester labeling.
Hu H; Dong Y; Feng P; Fechner J; Hamawy M; Knechtle SJ
Transplantation; 2003 Apr; 75(7):1075-7. PubMed ID: 12698107
[TBL] [Abstract][Full Text] [Related]
8. Ex vivo depletion of alloreactive cells based on CFSE dye dilution, activation antigen selection, and dendritic cell stimulation.
Godfrey WR; Krampf MR; Taylor PA; Blazar BR
Blood; 2004 Feb; 103(3):1158-65. PubMed ID: 14525783
[TBL] [Abstract][Full Text] [Related]
9. Identification and characterization of the antigen-specific subpopulation of alloreactive CD4+ T cells in vitro and in vivo.
Krieger NR; Fathman CG; Shaw MK; Ridgway WM
Transplantation; 2000 Feb; 69(4):605-9. PubMed ID: 10708118
[TBL] [Abstract][Full Text] [Related]
10. Recognition and response to alloantigens in vivo. I. Negative and positive selection of MLR reactivity in murine peripheral blood lymphocytes to major histocompatibility complex and Mls antigens.
Ryan JJ; Ahmed A; Kind PD; Thompson CB; Berning AK; Sell KW
J Immunol; 1984 Aug; 133(2):606-15. PubMed ID: 6234352
[TBL] [Abstract][Full Text] [Related]
11. Recognition and response to alloantigens in vivo. II. Priming with accessory cell-depleted donor allogeneic splenocytes: induction of specific unresponsiveness to foreign major histocompatibility complex determinants.
Ryan JJ; Gress RE; Hathcock KS; Hodes RJ
J Immunol; 1984 Nov; 133(5):2343-50. PubMed ID: 6207227
[TBL] [Abstract][Full Text] [Related]
12. Dendritic cells prime in vivo alloreactive CD4 T lymphocytes toward type 2 cytokine- and TGF-beta-producing cells in the absence of CD8 T cell activation.
Foucras G; Coudert JD; Coureau C; Guéry JC
J Immunol; 2000 Nov; 165(9):4994-5003. PubMed ID: 11046027
[TBL] [Abstract][Full Text] [Related]
13. In vivo MLR: a novel method for the study of alloimmune responses.
Song HK; Noorchashm H; Lieu YK; Rostami S; Greeley SA; Barker CF; Naji A
Transplant Proc; 1999; 31(1-2):834-5. PubMed ID: 10083362
[No Abstract] [Full Text] [Related]
14. Induction and characterization of minor histocompatibility antigens. Specific primary cytotoxic T lymphocyte responses in vitro.
Ando K; Nakashima I; Nagase F; Isobe K; Kawashima K; Hasegawa Y; Yoshida T; Iwamoto T; Hasegawa T; Muro Y
J Immunol; 1988 Feb; 140(3):723-9. PubMed ID: 2448374
[TBL] [Abstract][Full Text] [Related]
15. Fluorescent target array T helper assay: a multiplex flow cytometry assay to measure antigen-specific CD4+ T cell-mediated B cell help in vivo.
Quah BJ; Wijesundara DK; Ranasinghe C; Parish CR
J Immunol Methods; 2013 Jan; 387(1-2):181-90. PubMed ID: 23123200
[TBL] [Abstract][Full Text] [Related]
16. IL-17 production elicited by allo-major histocompatibility complex class II recognition depends on CD25posCD4pos T cells.
Benghiat FS; Craciun L; De Wilde V; Dernies T; Kubjak C; Lhomme F; Goldman M; Le Moine A
Transplantation; 2008 Apr; 85(7):943-9. PubMed ID: 18408572
[TBL] [Abstract][Full Text] [Related]
17. Increased antigen specific T cell numbers in the absence of altered migration or division rates as a result of mucosal cholera toxin administration.
Kaparakis-Liaskos M; Tate MD; Price JD; Pearse M; Wijburg OL
PLoS One; 2013; 8(3):e59934. PubMed ID: 23544110
[TBL] [Abstract][Full Text] [Related]
18. Cutting edge: alloimmune responses against major and minor histocompatibility antigens: distinct division kinetics and requirement for CD28 costimulation.
Song HK; Noorchashm H; Lieu YK; Rostami S; Greeley SA; Barker CF; Naji A
J Immunol; 1999 Mar; 162(5):2467-71. PubMed ID: 10072484
[TBL] [Abstract][Full Text] [Related]
19. Alloreactive CD4 T cell activation in vivo: an autonomous function of the indirect pathway of alloantigen presentation.
Reed AJ; Noorchashm H; Rostami SY; Zarrabi Y; Perate AR; Jeganathan AN; Caton AJ; Naji A
J Immunol; 2003 Dec; 171(12):6502-9. PubMed ID: 14662850
[TBL] [Abstract][Full Text] [Related]
20. Induction of acute graft-versus-host disease by T cells that do not respond to in vitro alloantigen stimulation.
New JY; Chan SH; Yap EH; Hu H
Br J Haematol; 2004 Sep; 126(6):828-36. PubMed ID: 15352987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
